Quartet™ Bad Oeynhausen Trial
QUOTA
1 other identifier
interventional
81
1 country
1
Brief Summary
Primary objective of this study is to evaluate whether the use of a quadripolar left ventricular (LV) electrode compared to a standard bipolar LV electrode leads to lower non-responder rates in patients undergoing cardiac resynchronization therapy (CRT)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 19, 2012
CompletedStudy Start
First participant enrolled
March 1, 2013
CompletedFirst Posted
Study publicly available on registry
May 9, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedJanuary 30, 2019
January 1, 2019
5.8 years
December 19, 2012
January 28, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Increase in peak oxygen consumption
6 months
Reduction of New York Heart Association (NYHA) functional class
6 months
Survival
6 months
Study Arms (2)
Quadripolar LV electrode
ACTIVE COMPARATORApplication of a quadripolar LV electrode
Bipolar LV electrode
ACTIVE COMPARATORApplication of a bipolar LV electrode
Interventions
Eligibility Criteria
You may qualify if:
- Indication for CRT-D implantation according to current guidelines
- Ischemic cardiomyopathy (ICM) or dilated cardiomyopathy (DCM)
- Sinus rhythm
- NYHA II-IV
- Age ≥ 18 years
- Written informed consent to participate in the study
You may not qualify if:
- Right bundle brunch block
- Valvular cardiomyopathy
- Patient receiving a non-transvenous LV electrode
- Known pregnancy
- Age \< 18 years
- Life expectancy \< 1 year
- Atrial fibrillation / atrial flutter at the time of enrolment
- Inability to provide informed consent
- Participation in another study with active therapeutic arm
- Regular follow-up in the study center within the first 6 months after implantation not guaranteed
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Cardiology, Heart and Diabetes Center North Rhine-Westphalia, Ruhr University Bochum
Bad Oeynhausen, 32545, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Klaus-Juergen Gutleben, M.D.
Heart and Diabetes Center North Rhine-Westphalia, Department of Cardiology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior cardiologist
Study Record Dates
First Submitted
December 19, 2012
First Posted
May 9, 2013
Study Start
March 1, 2013
Primary Completion
December 1, 2018
Study Completion
December 1, 2018
Last Updated
January 30, 2019
Record last verified: 2019-01